Company intelligence / Profile preview
SiNON Nano Sciences
Columbia, South Carolina, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
SiNON Nano Sciences has developed a patented carbon nanoparticle-based drug delivery platform that enables targeted, controlled release of therapeutics across the blood-brain barrier. The company’s preclinical data suggest improved bioavailability and reduced toxicity for both small molecules and biologics in neurological disease models. As of mid 2025, the company is seed-stage and focused on advancing R&D to determine its positioning as a platform or asset company.
- Therapeutic areas
- NeurologyOncology
- Modalities
- NanoparticleSmall molecule (as payload)Biologic (as payload)DNA (as payload)
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on SiNON Nano Sciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SiNON Nano Sciences.